Fig. 5From: Antibody against apolipoprotein-A1, non-alcoholic fatty liver disease and cardiovascular risk: a translational studyThe impact of AAA-1 on hepatocellular injury. CK-18 secretion (M65 and M30 forms) has increased only in supernatants of AAA-1 treated cells. Results are expressed as median with IQR and range of five independent experiments (N = 5). *P = 0.041, #P = 0.015, **P = 0.004, ##P = 0.004 by Mann–Whitney testBack to article page